These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29197661)

  • 1. Functional assessment of hepatobiliary secretion by
    Ørntoft N; Frisch K; Ott P; Keiding S; Sørensen M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1240-1244. PubMed ID: 29197661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary transport kinetics of the conjugated bile acid tracer
    Ørntoft NW; Munk OL; Frisch K; Ott P; Keiding S; Sørensen M
    J Hepatol; 2017 Aug; 67(2):321-327. PubMed ID: 28249726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human biodistribution, dosimetry, radiosynthesis and quality control of the bile acid PET tracer [N-methyl-
    Frisch K; Kjærgaard K; Horsager J; Schacht AC; Munk OL
    Nucl Med Biol; 2019; 72-73():55-61. PubMed ID: 31330413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs.
    Frisch K; Jakobsen S; Sørensen M; Munk OL; Alstrup AK; Ott P; Hofmann AF; Keiding S
    J Nucl Med; 2012 May; 53(5):772-8. PubMed ID: 22454486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET.
    Sørensen M; Munk OL; Ørntoft NW; Frisch K; Andersen KJ; Mortensen FV; Alstrup AK; Ott P; Hofmann AF; Keiding S
    J Nucl Med; 2016 Jun; 57(6):961-6. PubMed ID: 26966160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans.
    Schmassmann A; Fehr HF; Locher J; Lillienau J; Schteingart CD; Rossi SS; Hofmann AF
    Gastroenterology; 1993 Apr; 104(4):1171-81. PubMed ID: 7681796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic bile acid transport increases in the postprandial state: A functional
    Ørntoft NW; Gormsen LC; Keiding S; Munk OL; Ott P; Sørensen M
    JHEP Rep; 2021 Jun; 3(3):100288. PubMed ID: 34095797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.
    Lillienau J; Schteingart CD; Hofmann AF
    J Clin Invest; 1992 Feb; 89(2):420-31. PubMed ID: 1371123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    De Lombaerde S; Neyt S; Kersemans K; Verhoeven J; Devisscher L; Van Vlierberghe H; Vanhove C; De Vos F
    PLoS One; 2017; 12(3):e0173529. PubMed ID: 28273180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
    Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
    Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis of N-¹¹C-Methyl-Taurine-Conjugated Bile Acids and Biodistribution Studies in Pigs by PET/CT.
    Schacht AC; Sørensen M; Munk OL; Frisch K
    J Nucl Med; 2016 Apr; 57(4):628-33. PubMed ID: 26697965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic regeneration following radiation-induced liver injury is associated with increased hepatobiliary secretion measured by PET in Göttingen minipigs.
    Kjærgaard K; Weber B; Alstrup AKO; Petersen JBB; Hansen R; Hamilton-Dutoit SJ; Mortensen FV; Sørensen M
    Sci Rep; 2020 Jul; 10(1):10858. PubMed ID: 32616907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Measurement of Hepatic Drug Transporter Inhibition with Radiolabeled Bile Acids.
    De Lombaerde S; Neyt S; Vanhove C; De Vos F
    Methods Mol Biol; 2019; 1981():87-98. PubMed ID: 31016649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, in vitro characterization and preliminary imaging studies on fluorinated bile acid derivatives as PET tracers to study hepatic transporters.
    Testa A; Dall'Angelo S; Mingarelli M; Augello A; Schweiger L; Welch A; Elmore CS; Sharma P; Zanda M
    Bioorg Med Chem; 2017 Feb; 25(3):963-976. PubMed ID: 28011201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile salts and cholestasis.
    Maillette de Buy Wenniger L; Beuers U
    Dig Liver Dis; 2010 Jun; 42(6):409-18. PubMed ID: 20434968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of hepatobiliary transport PET imaging in liver function assessment: Evaluation of 3β-[
    De Lombaerde S; Devisscher L; Verhoeven J; Neyt S; Van Vlierberghe H; Vanhove C; De Vos F
    Nucl Med Biol; 2019; 68-69():40-48. PubMed ID: 30595544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
    de Lima Toccafondo Vieira M; Tagliati CA
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.